Abstract:BackgroundThe incorrect interpretation of missense and synonymous variants can lead to improper molecular diagnosis and subsequent faulty genetic counselling. The aim of this study was to evaluate the pathogenicity of presumed COL4A3/COL4A4 missense and synonymous variants detected by next-generation sequencing to provide evidence for diagnosis and genetic counselling. MethodsPatients' clinical findings and genetic data were analysed retrospectively. An in vitro minigene assay was conducted to assess the effect of presumed COL4A3/COL4A4 missense and synonymous variants on RNA splicing. ResultsFive unclassified COL4A3/COL4A4 variants, which were detected in five of 343 patients with hereditary kidney diseases, were analysed. All of them were predicted to affect splicing by Human Splicing Finder. The presumed COL4A3 missense variant c.4793T > G [p. (Leu1598Arg)] resulted in a loss of alternative full-length transcript during the splicing process. The COL4A3 transcript carried synonymous variant c.765G > A [p. (Thr255Thr)], led to an in-frame deletion of exon 13. Nevertheless, variants c.3566G > A [p. (Gly1189Glu)] in COL4A3 and c.3990G > A [p. (Pro1330Pro)], c.4766C > T [p. (Pro1589Leu)] in COL4A4 exhibited no deleterious effect on splicing. Among the five patients harbouring the abovementioned COL4A3/COL4A4 variants, three patients were genetically diagnosed with autosomal recessive Alport syndrome, one patient was highly suspected of having thin basement membrane nephropathy, and the other patient was clinically diagnosed with Alport syndrome. ConclusionsCOL4A3 presumed missense variant p. (Leu1598Arg) and synonymous variant p. (Thr255Thr) affect RNA splicing, which highlights the prime importance of transcript analysis of unclassified exonic sequence variants for better molecular diagnosis and genetic counselling. Meanwhile, the reliability of splicing predictions by predictive tools for exonic substitutions needs to be improved.

Effects of 14 <i>F9</i> synonymous codon variants on hemophilia B expression: Alteration of splicing along with protein expression

An Intronic Mutation C.6430-3C>g in the F8 Gene Causes Splicing Efficiency and Premature Termination in Hemophilia A

Pleiotropic effects of different exonic nucleotide changes at the same position contribute to hemophilia B phenotypic variation

Synonymous Variant at the Terminal Nucleotide in Exon 3 of F7 Causes Abnormal Splicing: A Case Report

Characterisation and Quantification of F8 Transcripts of Ten Putative Splice Site Mutations

Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor

Identification of Mutations in the F8 and F9 Gene in Families with Haemophilia Using Targeted High-Throughput Sequencing.

Molecular pathogenesis of two novel splice site mutations of F8 in hemophilia A

Characterization of missense mutations in the signal peptide and propeptide of FIX in hemophilia B by a cell-based assay

A Genetic Analysis of 23 Chinese Patients with Hemophilia B

Variant spectrum of F8 and F9 in hemophilia patients from southern China and 26 novel variants

Multimodal mechanisms of pathogenic variants in the signal peptide of FIX leading to hemophilia B

Structural and Functional Exploration of Three Newly Identified Coagulation Factor IX Mutations in Chinese Hemophilia B Patients

Characterization of two large duplications of F9 associated with mild and severe haemophilia B, respectively.

Presumed COL4A3/COL4A4 Missense/Synonymous Variants Induce Aberrant Splicing

Splicing Analysis of Rare/novel Synonymous or Intronic Variants Identified in ABCB11 Heterozygotes Presenting As Progressive Intrahepatic Cholestasis with Low Γ‐glutamyltransferase

Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations

An updated interactive database for 1692 genetic variants in coagulation factor IX provides detailed insights into hemophilia B

[Altered Splicing in Stable Cell Strains Expressing Mini-hF9 Gene with Nonsense Mutation].

Understanding the Impact of Aberrant Splicing in Coagulation Factor V Deficiency

Spectrum of F9 mutations in Chinese haemophilia B patients: identification of 20 novel mutations